Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3145093rdf:typepubmed:Citationlld:pubmed
pubmed-article:3145093lifeskim:mentionsumls-concept:C1273518lld:lifeskim
pubmed-article:3145093lifeskim:mentionsumls-concept:C0442874lld:lifeskim
pubmed-article:3145093lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:3145093lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3145093lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:3145093pubmed:issue1lld:pubmed
pubmed-article:3145093pubmed:dateCreated1989-2-22lld:pubmed
pubmed-article:3145093pubmed:abstractTextThe present studies were carried out to investigate the comparative roles of protein cross-linking and alteration in protein phosphorylation in the accumulation of neurofilaments due to aliphatic hexacarbons. In these studies, rats were given 2,5-hexanedione (0, 0.1, 0.25 and 1.0%) for 70 days in their drinking water. In a separate study of in vitro protein phosphorylation rats were given 1% 2,5-hexanedione for 14 days in their drinking water. Spinal cord neurofilaments were isolated and analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunoblotting using anti-neurofilament antibodies, radioimmunoassays (RIAs) of phosphorylated epitopes on neurofilament proteins and protein phosphorylation. Protein cross-linking of neurofilaments was found in all animals treated with 2,5-hexanedione including the lowest dose (0.1%) which did not produce clinical signs of intoxication. Protein phosphorylation of neurofilament proteins, as well as MAP-2 was significantly decreased upon treatment. Protein staining revealed a decreased amount of neurofilament protein and immunoblotting demonstrated neurofilament protein cross-linking in these animals. Protein staining of glial fibrillary acidic protein (GFAP) was unaltered by this treatment. RIAs of phosphorylated and non-phosphorylated epitopes of neurofilament proteins indicated that in vivo phosphorylation of these proteins was also decreased. Two-dimensional gel electrophoresis indicated a shift of the neurofilament proteins to a basic pI, indicating a dephosphorylation of neurofilament proteins. Cross-linked neurofilament proteins also exhibited a pI which was more basic than any of the individual neurofilament proteins. This report demonstrates differential effects of 2,5-hexanedione on neurofilament proteins and indicates that several mechanisms may be responsible for their accumulation.lld:pubmed
pubmed-article:3145093pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:languageenglld:pubmed
pubmed-article:3145093pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:citationSubsetIMlld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3145093pubmed:statusMEDLINElld:pubmed
pubmed-article:3145093pubmed:monthAuglld:pubmed
pubmed-article:3145093pubmed:issn0006-8993lld:pubmed
pubmed-article:3145093pubmed:authorpubmed-author:Abou-DoniaM...lld:pubmed
pubmed-article:3145093pubmed:authorpubmed-author:LapadulaD MDMlld:pubmed
pubmed-article:3145093pubmed:authorpubmed-author:SuwitaEElld:pubmed
pubmed-article:3145093pubmed:issnTypePrintlld:pubmed
pubmed-article:3145093pubmed:day16lld:pubmed
pubmed-article:3145093pubmed:volume458lld:pubmed
pubmed-article:3145093pubmed:ownerNLMlld:pubmed
pubmed-article:3145093pubmed:authorsCompleteYlld:pubmed
pubmed-article:3145093pubmed:pagination123-31lld:pubmed
pubmed-article:3145093pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:meshHeadingpubmed-meshheading:3145093-...lld:pubmed
pubmed-article:3145093pubmed:year1988lld:pubmed
pubmed-article:3145093pubmed:articleTitleEvidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy.lld:pubmed
pubmed-article:3145093pubmed:affiliationDepartment of Pharmacology, Duke University Medical Center, NC 27710.lld:pubmed
pubmed-article:3145093pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3145093pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed